{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:20:03Z","timestamp":1792678803245,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1136\/ard.2009.113696","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T21:04:26Z","timestamp":1253653466000},"page":"325-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1121,"title":["EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis"],"prefix":"10.1016","volume":"69","author":[{"given":"M J L","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D P M","family":"Symmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"McCarey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B A C","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T K","family":"Kvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I B","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Haentzschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Gonzalez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Provan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Semb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y M","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M T","family":"Nurmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.113696_bib1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","article-title":"Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?","volume":"46","author":"Van Doornum","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","article-title":"Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.","volume":"34","author":"Peters","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib5","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.HYP.0000168055.89955.db","article-title":"Arterial stiffness in chronic inflammatory diseases.","volume":"46","author":"Roman","year":"2005","journal-title":"Hypertension"},{"key":"10.1136\/ard.2009.113696_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-144-4-200602210-00006","article-title":"Preclinical carotid atherosclerosis in patients with rheumatoid arthritis.","volume":"144","author":"Roman","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.113696_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"key":"10.1136\/ard.2009.113696_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.2003.018101","article-title":"Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study.","volume":"63","author":"Turesson","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib11","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1136\/ard.2009.113696_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories.","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1136\/ard.2009.113696_bib15","doi-asserted-by":"crossref","first-page":"R186","DOI":"10.1186\/ar2098","article-title":"Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis.","volume":"8","author":"Chung","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113696_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib17","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1002\/art.22979","article-title":"The widening mortality gap between rheumatoid arthritis patients and the general population.","volume":"56","author":"Gonzalez","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib18","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/01.CIR.0000142864.83780.81","article-title":"Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.","volume":"110","author":"Krishnan","year":"2004","journal-title":"Circulation"},{"key":"10.1136\/ard.2009.113696_bib19","first-page":"906","article-title":"Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964\u201395.","volume":"29","author":"Bjornadal","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/030097400750001770","article-title":"Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992.","volume":"29","author":"Kvalvik","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib21","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis.","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2008.094151","article-title":"Rheumatoid arthritis versus type 2 diabetes as a risk factor for cardiovascular disease: a cross-sectional study.","volume":"68","author":"van Halm","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis.","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113696_bib24","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/art.20636","article-title":"Cardiovascular risk factors in women with and without rheumatoid arthritis.","volume":"50","author":"Solomon","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.2006.059980","article-title":"Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?","volume":"67","author":"Gonzalez","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/rheumatology\/keh161","article-title":"Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis.","volume":"43","author":"Goodson","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113696_bib27","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.21349","article-title":"How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?","volume":"52","author":"Crowson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib28","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis.","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1136\/ard.2009.113696_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.113696_bib30","first-page":"937","article-title":"Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis.","volume":"34","author":"Aubry","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study.","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib33","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib34","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/1529-0131(200105)44:5<1170::AID-ANR200>3.0.CO;2-T","article-title":"Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.","volume":"44","author":"Jacobsson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib35","first-page":"2562","article-title":"Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.","volume":"26","author":"Wallberg-Jonsson","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib36","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2323","article-title":"Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation.","volume":"9","author":"Hannawi","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113696_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/art.10748","article-title":"Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation.","volume":"48","author":"Wong","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib38","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.11327","article-title":"Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis.","volume":"48","author":"Nagata-Sakurai","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1136\/ard.2009.113696_bib40","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib41","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113696_bib42","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2006.067660","article-title":"All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists.","volume":"66","author":"Carmona","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib43","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113696_bib44","first-page":"1072","article-title":"Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.","volume":"25","author":"Symmons","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib45","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ard.58.2.79","article-title":"Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.","volume":"58","author":"Haagsma","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib47","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease.","volume":"324","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.113696_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","article-title":"Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.","volume":"41","author":"van Ede","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113696_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jada.2007.12.001","article-title":"Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.","volume":"108","author":"Woolf","year":"2008","journal-title":"J Am Diet Assoc"},{"key":"10.1136\/ard.2009.113696_bib50","first-page":"441","article-title":"Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.","volume":"25","author":"Morgan","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","article-title":"Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.","volume":"43","author":"Whittle","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113696_bib52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/art.23402","article-title":"The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis.","volume":"58","author":"Naz","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib53","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/1529-0131(200106)44:6<1467::AID-ART243>3.0.CO;2-6","article-title":"Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?","volume":"44","author":"Ward","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib54","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.1780360804","article-title":"Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.","volume":"36","author":"Jacobsson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis.","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113696_bib56","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis.","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis.","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2006.052506","article-title":"Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis.","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib61","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis.","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib62","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"key":"10.1136\/ard.2009.113696_bib63","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jama.1988.03410050061031","article-title":"Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.","volume":"260","author":"Manninen","year":"1988","journal-title":"JAMA"},{"key":"10.1136\/ard.2009.113696_bib64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: predicting risks by levels and ratios.","volume":"121","author":"Kinosian","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.113696_bib65","first-page":"2311","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis\u2014the Third National Health and Nutrition Examination Survey.","volume":"32","author":"Choi","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib66","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis.","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib67","first-page":"1746","article-title":"Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.","volume":"31","author":"Yoo","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis.","volume":"66","author":"van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.56.6.374","article-title":"Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis.","volume":"56","author":"Munro","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib70","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.","volume":"113","author":"Park","year":"2002","journal-title":"Am J Med"},{"key":"10.1136\/ard.2009.113696_bib71","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib72","first-page":"252","article-title":"Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.","volume":"32","author":"Vis","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib73","first-page":"2440","article-title":"Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.","volume":"33","author":"Spanakis","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib74","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.","volume":"64","author":"Popa","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib75","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2014a prospective, controlled study.","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113696_bib76","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/ard.2006.066191","article-title":"Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.","volume":"66","author":"Popa","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib77","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2006.059691","article-title":"Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.","volume":"66","author":"Peters","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib78","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2009.113696_bib79","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1136\/ard.2009.113696_bib80","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1191\/0961203303lu429oa","article-title":"Therapy with statins in patients with refractory rheumatic diseases: a preliminary study.","volume":"12","author":"bud-Mendoza","year":"2003","journal-title":"Lupus"},{"key":"10.1136\/ard.2009.113696_bib81","first-page":"964","article-title":"Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort.","volume":"34","author":"Okamoto","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib82","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis.","volume":"50","author":"Maki-Petaja","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1136\/ard.2009.113696_bib83","first-page":"2095","article-title":"Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.","volume":"32","author":"Tikiz","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib84","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/ard.2005.044503","article-title":"Statin therapy might be beneficial for patients with ankylosing spondylitis.","volume":"65","author":"van Denderen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib85","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.107.734384","article-title":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis.","volume":"117","author":"Flammer","year":"2008","journal-title":"Circulation"},{"key":"10.1136\/ard.2009.113696_bib86","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1592\/phco.2005.25.9.1213","article-title":"Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.","volume":"25","author":"Dagenais","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1136\/ard.2009.113696_bib87","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(84)91821-X","article-title":"Captopril: a new treatment for rheumatoid arthritis?","volume":"1","author":"Martin","year":"1984","journal-title":"Lancet"},{"key":"10.1136\/ard.2009.113696_bib88","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/ard.2005.036269","article-title":"Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs.","volume":"65","author":"Bolten","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib89","doi-asserted-by":"crossref","unstructured":"Garner SE, Fidan DD, Frankish RR, et al. Rofecoxib for rheumatoid arthritis. Cochrane Database Syst Rev 2005;(1):CD003685.","DOI":"10.1002\/14651858.CD003685.pub2"},{"key":"10.1136\/ard.2009.113696_bib90","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.2007.076760","article-title":"Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.","volume":"68","author":"Goodson","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 4","key":"10.1136\/ard.2009.113696_bib91","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1186\/ar1795","article-title":"Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.","volume":"7","author":"Scheiman","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.113696_bib92","first-page":"1403","article-title":"Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.","volume":"33","author":"Crofford","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib93","first-page":"1589","article-title":"Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction.","volume":"32","author":"Hudson","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib94","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.20905","article-title":"Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.","volume":"53","author":"Greenberg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.113696_bib95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib96","first-page":"867","article-title":"Glucocorticoids and insulin sensitivity in rheumatoid arthritis.","volume":"31","author":"Dessein","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.113696_bib97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","article-title":"Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.113696_bib98","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.0954-6820.1983.tb03750.x","article-title":"Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids.","volume":"213","author":"Hallgren","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1136\/ard.2009.113696_bib99","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.62.11.1033","article-title":"Glucocorticoids in the treatment of early and late RA.","volume":"62","author":"Bijlsma","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.113696_bib101","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2009.113696_bib102","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672419615X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672419615X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.113696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:34:29Z","timestamp":1737333269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672419615X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S000349672419615X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.113696","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1166125.627039","asserted-by":"object"}]},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.113696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Publishing Group Ltd and European League Against Rheumatism. All rights reserved. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}